CYCLURAD Trademark

Trademark Overview

On Friday, July 9, 2021, a trademark application was filed for CYCLURAD with the United States Patent and Trademark Office. The USPTO has given the CYCLURAD trademark a serial number of 90819317. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Wednesday, October 11, 2023. This trademark is owned by NeuroRx, Inc.. The CYCLURAD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of depression
cyclurad

General Information

Serial Number90819317
Word MarkCYCLURAD
Filing DateFriday, July 9, 2021
Status732 - THIRD EXTENSION - GRANTED
Status DateWednesday, October 11, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of depression

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 16, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNeuroRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801
Party NameNeuroRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Trademark Events

Event DateEvent Description
Friday, October 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 11, 2023SOU EXTENSION 3 GRANTED
Wednesday, October 11, 2023SOU EXTENSION 3 FILED
Wednesday, October 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 20, 2023SOU EXTENSION 2 GRANTED
Monday, March 20, 2023SOU EXTENSION 2 FILED
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 22, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 12, 2022SOU EXTENSION 1 FILED
Monday, November 21, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 20, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, October 20, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, October 20, 2022PETITION TO REVIVE-GRANTED
Thursday, October 20, 2022TEAS PETITION TO REVIVE RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Thursday, September 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 13, 2021NEW APPLICATION ENTERED

Related Keywords

cyclurad depression treatment preparations pharmaceutical